Fostamatinib, a spleen tyrosine kinase inhibitor, exerts excellent anti-inflammatory activity via inhibiting STAT1/3 signaling pathways

Published: 26 June 2024| Version 1 | DOI: 10.17632/x6nnxygn48.1
Contributor:
Ran Guo

Description

Transcriptome sequencing data of fostamatinib

Files

Categories

Medicine

Licence